Challenges of Manufacturing Bi/Multispecific Modalities

This research article explores the growing focus on bi/multispecific antibodies in the pharmaceutical industry, highlighting their potential benefits, market growth, and the manufacturing challenges associated with these complex modalities. With an increasing number of bispecific antibodies in clinical development, the article discusses advancements in protein engineering and the innovative solutions being developed to overcome manufacturing hurdles.